ArticleJournal of the American Society for Mass Spectrometry2025
Accelerating Characterization of Therapeutic Antibodies: A Comparative Assessment of icIEF-UV/MS and the Traditional Fractionation Workflow.
Article in Journal of the American Society for Mass Spectrometry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate characterization of charge variants in biologics is crucial to uphold stringent quality standards ensuring the safety and efficacy of biotherapeutic products and regulatory requirements for the Biologic Licensing Application (BLA) process enabling marketing application. These variants, arising from post-translational modifications (PTMs) during upstream processing and enzymatic/nonenzymatic reactions in downstream processing and storage, can significantly impact therapeutic potency, efficacy, and immunogenicity. Conventional methods for characterizing charge variants typically involve labor-intensive fraction enrichment, consuming time and resources. However, recent technological advancements, exemplified by the Intabio ZT system's innovative platform, enable the seamless and direct integration of imaged capillary isoelectric focusing (icIEF) and UV quantitation with mass spectrometry (MS) PTM identification, facilitating rapid and unbiased characterization. In this study, we conduct a comparative assessment of the charge variant characterization of investigative mAb-1 using icIEF-UV/MS analysis and a traditional fractionation-based workflow. Our results demonstrated that icIEF-UV/MS-based proteoform characterization provided comparable icIEF-UV separation and quantitation and superior direct MS-based peak characterization with shorter time and less sample processing compared to conventional fractionation approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.